Natural look in volume restoration

Journal of Drugs in Dermatology

Volumn 7, Issue 9, 2008, Pages 833-839

  Lupo, Mary P ^a,b  

^a Lupo Center for Aesthetic and General Dermatology   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ARTICLE; CUTANEOUS PARAMETERS; ESTHETIC SURGERY; FACE; HUMAN; REJUVENATION;

BIOCOMPATIBLE MATERIALS; COSMETIC TECHNIQUES; FACE; HUMANS; REJUVENATION; SKIN AGING;

EID: 58249087891     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthetic Surg J. 2004;24:33-43.
2. Zyplast® package insert. Available at: http://www.allerganandinamed. com/pdf/us-aesthetics/M760A-Zyplast-DFU.pdf. Accessed March 2008.
3. Zyderm® package insert. Available at: http://www.allerganandinamed. com/pdf/us-aesthetics/M761A-Zyderm-DFU.pdf. Accessed March 2008.
4. Baumann LS, Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg. 1999;25:247-249. (Pubitemid 29146995)
5. Moscona RR, Bergman R, Friedman-Birnbaum R. An unusual late reaction to Zyderm I injections: a challenge for treatment. Plast Reconstr Surg. 1993;92:331-334. (Pubitemid 23226879)
6. Ruiz-Esparza J, Bailin M, Bailin PL. Necrobiotic granuloma formation at a collagen implant treatment site. Cleve Clin Q. 1983;50:163-165. (Pubitemid 14233644)
7. Hanke CW, Higley HR, Jolivette DM, et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol. 1991;25:319-326.
8. Maloney BP, Murphy BA, Cole HP 3rd. Cymetra. Facial Plast Surg. 2004;20:129-134. (Pubitemid 40075169)
9. Sclafani AP, Romo T, 3rd, Jacono AA. Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra). Arch Facial Plast Surg. 2002;4:252-257.
10. Burres S. Preserved particulate fascia lata for injection: a new alternative. Dermatol Surg. 1999;25:790-794. (Pubitemid 29480973)
11. The American Academy of Facial Plastic and Reconstructive Surgery. American Academy of Facial Plastic and Reconstructive Surgery 2006 Membership Survey: Trends in Facial Plastic Surgery. Available at: http://www.aafprs.org/ media/stats-polls/aafprsMe-dia2006.pdf. Accessed March 2008.
12. Baumann L. Replacing dermal constituents lost through aging with dermal fillers. Semin Cutan Med Surg. 2004;23:160-166. (Pubitemid 39458103)
13. Born T. Hyaluronic acids. Clin Plast Surg. 2006;33:525-538. (Pubitemid 44679716)
14. Matarasso SL, Carruthers JD, Jewell ML. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg. 2006;117:3S-34S; discussion 35S-43S.
15. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005;23:343-363.
16. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595. (Pubitemid 36702442)
17. Baumann LS, Shamban AT, Lupo MP, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33 S128-135.
18. Lupo MP, Smith SR, Thomas JA, et al. Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008;121:289-297.
19. Carruthers A, Carey W, De Lorenzi C, et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005;31:1591-1598.
20. Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006;17:471-479. (Pubitemid 44319040)
21. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28:491-494. (Pubitemid 34686633)
22. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-933. (Pubitemid 33096637)
23. Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg. 2006;25:122-126. (Pubitemid 44572815)
24. Hirsch RJ, Lupo M, Cohen JL, et al. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol. 2007;6:325-328.
25. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118:7S-14S.
26. Jacovella PF, Peiretti CB, Cunille D, et al. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg. 2006;118:15S-21S.
27. Sklar JA, White SM. Radiance FN: a new soft tissue filler. Dermatol Surg. 2004;30:764-768; discussion 768.
28. Roy D, Sadick N, Mangat D. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres. Dermatol Surg. 2006;32:1134-1139. (Pubitemid 44370117)
29. Silvers SL, Eviatar JA, Echavez MI, et al. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial softtissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg. 2006;118:34S-45S.
30. Radiesse® Physician frequently asked questions. Available at: http://www.radiesse.com/physicians/faq/#how-long-will-radiesse. Accessed April 2008.
31. Flaharty P. Radiance. Facial Plast Surg. 2004;20:165-169. (Pubitemid 40075175)
32. Vleggaar D, Bauer U. Facial enhancement and the European experience with poly-L-lactic acid. J Drugs Dermatol. 2004;3:526-530.
33. Moyle GJ, Brown S, Lysakova L, et al. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7:181-185. (Pubitemid 43337597)
34. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Poly-L-lactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17:2471-2477. (Pubitemid 38393319)
35. Vleggaar D. Soft tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118:46S-54S.
36. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135-1148. (Pubitemid 23241077)
37. Sculptra® Product Information. sanofi-aventis; 2006. Available at: http://products.sanofi-aventis.us/sculptra/sculptra.html. Accessed August 2007.
38. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed poly-L-lactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5:82-87. (Pubitemid 38404660)
39. Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg. 2005;31:1511-1517.
40. Engelhard P, Humble G, Mest D. Safety of Sculptra®: a review of clinical trial data. J Cosmet Laser Ther. 2005;7:201-205. (Pubitemid 43111922)
41. Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006;118:55S-63S.
42. Vleggaar D. Poly-l-lactic acid: consultation on the injection techniques. J Eur Acad Dermatol Venereol. 2006;20:17-21.
43. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29:573-587. (Pubitemid 36702440)
44. Cohen SR, Berner CF, Busso M, et al. ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg. 2006;118:64S-76S.
45. American society of plastic surgeons. Available at: http://www. plasticsurgery.org/patients-consumers/procedures/InjectableFillers.cfm#four. Accessed April 2008.
46. Sommer B, Sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg. 2000;26:1159-1166. (Pubitemid 32064720)
47. Guaraldi G, Orlando G, De Fazio D, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005;10:753-759. (Pubitemid 41376855)